A Study to Evaluate the Long Term Safety and Efficacy of Bimekizumab in Subjects With Ankylosing Spondylitis
Clinical trial NCT03355573 · COMPLETED
Trial details
- NCT number
- NCT03355573
- Sponsor
- UCB Biopharma SRL
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2022-10-19
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.